Johnson & Johnson stock outperforms competitors despite losses on the day
Johnson & Johnson closed $25.19 below its 52-week high ($168.85), which the company reached on September 4th.
STAT3h
Johnson & Johnson says its lung cancer drug significantly extended survival
Johnson & Johnson says its bispecific antibody, paired with a Janssen drug, could change treatment for non-small lung cancer ...